Aztreonam/Avibactam

阿维巴坦钠/氨曲南

Report date: 2025/06/30 17:34:04
QIDP

Base Information

Drug NameAztreonam/Avibactam
Drug Alias NameAztreonam-avibactam氨曲南/阿维巴坦钠Aztreonam/Avibactam SodiumAztreonam/avibactamAvibactam/Aztreonam +[11] 
ClassificationSmall molecules
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsHospital-acquired pneumoniaRenal InsufficiencyPyelonephritis +[9] 
Global Approved IndicationsHospital-acquired pneumoniaPyelonephritisUrinary Tract Infections +[6] 
Approved Indications in ChinaHospital-acquired pneumoniaIntraabdominal InfectionsPneumonia, Ventilator-Associated +[4] 
Original Approved Country/TerritoryEU
Original Approved Date2024/04/22
Country/TerritoryCzechiaBulgariaUnited States +[24] 
CombinationsYes Aztreonam
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca PlcAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncAbbvie IncHospira Australia Pty Ltd +[5] 
Inactive CompaniesAllergan Plc
Active IndicationsHospital-acquired pneumoniaRenal InsufficiencyPyelonephritis +[8] 
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A